Anticonvulsant drugs

Trimble, 1990, Antiepileptic drugs, cognitive function and behaviour in children: evidence from recent studies, Epilepsia, 31, S30, 10.1111/j.1528-1157.1990.tb05867.x Forsythe, 1991, Cognitive impairment in new cases of epilepsy randomly assigned to carbamazepine, phenytoin and sodium valproate, Dev. Med. Child Neurol., 33, 524, 10.1111/j.1469-8749.1991.tb14917.x Gillham, 1990, Cognitive function in adult epileptic patients established on anti-convulsant monotherapy, Epilepsy Res., 7, 219, 10.1016/0920-1211(90)90018-Q Gaily, 1990, Specific cognitive dysfunction in children with epileptic mothers, Dev. Med. Child Neurol., 32, 403, 10.1111/j.1469-8749.1990.tb16959.x Wheeler, 1991, Metabolic clearance rate of testosterone in male epileptic patients on anti-convulsant therapy, J. Endocrinol., 129, 465, 10.1677/joe.0.1290465 Isojärvi, 1990, Serum steroid hormones and pituitary function in female epileptic patients during carbamazepine therapy, Epilepsia, 31, 438, 10.1111/j.1528-1157.1990.tb05500.x Renri, 1991, Antiepileptic drugs and bone atrophy—a 3-year follow-up study, J. Jpn. Epilepsy Soc., 9, 14, 10.3805/jjes.9.14 Calandre, 1991, Serum lipids, lipoproteins and apolipoproteins A and B in epileptic patients treated with valproic acid, carbamazepine or phenobarbital, Acta Neurol. Scand., 83, 250, 10.1111/j.1600-0404.1991.tb04691.x Nijhawan, 1990, Antiepileptic drugs, hepatic enzyme induction and raised serum alkaline phosphatase isoenzymes, Int. J. Clin. Pharmacol. Res., X, 319 Resor, 1990, Chronic acetazolamide monotherapy in the treatment of juvenile myoclonic epilepsy, Neurology, 40, 1677, 10.1212/WNL.40.11.1677 Pellock, 1989, Carbamazepine: a retrospective usage survey of prescribing and monitoring habits, J. Epilepsy, 2, 169, 10.1016/0896-6974(89)90032-7 Kennebäck, 1991, Electro-physiologic effects and clinical hazards of carbamazepine treatment for neurologic disorders in patients with abnormalities of the cardiac conduction system, Am. Heart J., 121, 1421, 10.1016/0002-8703(91)90148-B Barreiro, 1990, Carbamazepine and the lung, Eur. Respir. J., 3, 930, 10.1183/09031936.93.03080930 Buitendag, 1990, Pure red-cell aplasia associated with carbamazepine, South Afr. Med. J., 78, 214 Frey, 1990, Transient cholestatic hepatitis in a neonate associated with carbamazepine exposure during pregnancy and breast-feeding, Eur. J. Pediatr., 150, 136, 10.1007/BF02072057 Atkin, 1990, Carbamazepine-induced lichenoid eruption, Clin. Exper. Dermatol., 15, 382, 10.1111/j.1365-2230.1990.tb02122.x Ohtsuyama, 1990, Two cases of lichenoid drug eruption localised in the nails, Acta Dermatol., 85, 221 Murphy, 1991, Suppression of carbamazepine-induced rash with prednisone, Neurology, 41, 144, 10.1212/WNL.41.1.144 Hosoda, 1991, Anticarbamazepine antibody induced by carbamazepine in a patient with severe serum sickness, Arch. Dis. Child., 66, 722, 10.1136/adc.66.6.722 Rosa, 1991, Spina bifida in infants of women treated with carbamazepine during pregnancy, N. Engl. J. Med., 324, 674, 10.1056/NEJM199103073241006 Legido, 1991, Congenital rib anomalies in a fetus exposed to carbamazepine, Clin. Peidatr., 30, 63, 10.1177/000992289103000112 West, 1990, Carbamazepine, epilepsy, and optic nerve hypoplasia, Br. J. Ophthalmol., 74, 511, 10.1136/bjo.74.8.511-a De Vries, 1990, Risico's van diazepam bij pasgeborenen, Ned. Tijdschr. Geneeskd., 134, 1708 Rankin, 1990, Acute effects of the antiepileptic succinimides on the urinary tract and potentiation of phensuximide-induced urotoxicity by phenobar-bital, J. Appl. Toxicol., 10, 203, 10.1002/jat.2550100311 Haider, 1990, Phenytoin-induced choreoathetosis, Postgrad, 66, 1089, 10.1136/pgmj.66.782.1089 Peñarrocha-Diago, 1990, Diphenylhydantoin-induced gingival overgrowth in man: a clinico-pathological study, J. Periodontol., 61, 571, 10.1902/jop.1990.61.9.571 Sooriyamoorthy, 1989, Phenytoin stimulation of 5-alpha-reductase activity in inflamed gingival fibroblasts, Med. Sci. Res., 17, 989 Rodríguez-García, 1991, Phenytoin-induced benign lymphadenopathy with solid spleen lesions mimicking a maligant lymphoma, Ann. Oncol., 2, 443, 10.1016/S0923-7534(20)30580-9 Gutiérrez-Ravé, 1991, Phenytoin-induced hemocytophagic histiocytosis indistinguishable from malignant histiocytosis, South. Med. J., 84, 649 Britigan, 1991, Diphenylhydantoin-induced hypogamma-globulinaemia in a patient infected with Human Immunodeficiency Virus, Am. J. Med., 90, 524, 10.1016/0002-9343(91)90616-6 D'Souza, 1990, Fetal phenytoin exposure, hypoplastic nails, and jitteriness, Arch. Dis. Child., 65, 320 Narcy, 1990, Intoxication grave par la phénytoine intraveineuse chez le nouveau-né: intérêt de la dialyse péritonéale, Arch. Fr. Pédiatr., 47, 591 Zifkin, 1991, Phenytoin toxicity due to interaction with clobazam, Neurology, 41, 313, 10.1212/WNL.41.2_Part_1.313 Wakisaka, 1990, Acute phenytoin intoxication associated with the antineoplastic agent UFT, Fukuoki Acta Med., 81, 192 Jones, 1991, Sodium valproate-induced mentstrual disturbance in young women, Hormone Res., 35, 82, 10.1159/000181878 Coulter, 1991, Carnitine, valproate, and toxicity, J. Child Neurol., 6, 7, 10.1177/088307389100600102 Ganick, 1990, Severe hematologic toxicity of valproic acid: a report of four patients, Am. J. Pediatr. Hematol./Oncol., 12, 80, 10.1097/00043426-199021000-00016 Watts, 1990, Valproic acid-induced cytopenia: evidence for dose-related suppression of hematopoiesis, J. Pediatr., 117, 495, 10.1016/S0022-3476(05)81105-9 Kreuz, 1990, Induction of von Willebrand disease type 1 by valproic acid, Lancet, 335, 1350, 10.1016/0140-6736(90)91235-3 Behari, 1991, Gingival hyperplasia due to sodium valproate, J. Neurol. Neurosurg. Psychiatry, 54, 279, 10.1136/jnnp.54.3.279-a Syrjanen, 1979, Hyperplastic gingivitis in a child receiving sodium valproate, 75, 95 Kamper, 1991, Cutaneous vasculitis dinduced by sodium valproate, Lancet, 337, 497, 10.1016/0140-6736(91)93438-F Bleck, 1990, Possible induction of systemic lupus erythematosus by valproate, Epilepsia, 31, 343, 10.1111/j.1528-1157.1990.tb05386.x Cotariu, 1991, Development toxicity of valproic acid, Life Sci., 48, 1341, 10.1016/0024-3205(91)90430-J Ben-Menachem, 1990, Long-term evaluation of once daily vigabatrin in drug-resistant partial epilepsy, Epilepsy Res., 5, 240, 10.1016/0920-1211(90)90045-W Browne, 1991, Multicenter longerm safety and efficacy study of vigabatrin for refractory complex partial seizures: an update, Neurology, 41, 363, 10.1212/WNL.41.3.363 Ring, 1990, Vigabatrin: rational treatment for chronic epilepsy, J. Neurol. Neurosurg. Psychiatry, 53, 1051, 10.1136/jnnp.53.12.1051 1990, Vigabatrin—a new anticonvulsant, Drug Ther. Bull., 28, 95, 10.1136/dtb.28.24.95 Tartara, 1989, Vigabatrin in the treatment of epilepsy: a long-term follow-up study, J. Neurol. Neurosurg. Psychiatry, 62, 467, 10.1136/jnnp.52.4.467 Sander, 1991, Vigabatrin and psychosis, J. Neurol. Neurosurg. Psychiatry, 54, 435, 10.1136/jnnp.54.5.435 Brodie, 1990, Vigabatrin and psychosis, Lancet, 335, 1279, 10.1016/0140-6736(90)91342-8 Shih, 1990, Aminoaciduria due to vinyl-GABA administration, N. Engl. J. Med., 323, 1353, 10.1056/NEJM199011083231918 Rentmeester, 1991, Long-term evaluation of the efficacy and safety of loreclezole as add-on therapy in patients with uncontrolled partial seizures: a 1 year open follow-up, Epilepsy Res., 9, 65, 10.1016/0920-1211(91)90048-K Iivainen, 1990, A controlled study with taltrimide and sodium valproate: valproate effective in partial epilepsy, Acta Neurol. Scand., 82, 121, 10.1111/j.1600-0404.1990.tb01600.x Charles, 1990, Zonisamide-induced mania, Psychosomatics, 31, 214, 10.1016/S0033-3182(90)72198-6